13.50
+0.19
+(1.43%)
At close: January 30 at 4:00:00 PM EST
13.20
-0.35
(-2.58%)
Pre-market: 7:07:26 AM EST
Insider purchases - Last 6 months
| Shares | Transactions | |
|---|---|---|
| Purchases | -- | -- |
| Sales | -- | -- |
| Net shares purchased (sold) | -- | -- |
| Total insider shares held | -- | -- |
| % net shares purchased (sold) | -- | -- |
Net institutional purchases - Prior quarter to latest quarter
| Shares | |
|---|---|
| Net shares purchased (sold) | -- |
| % change in institutional shares held | -- |
Insider transactions reported - last two years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| JENKINS GEORGE Director | Purchase at price 12.93 per share. | Direct | 51,720 | Dec 18, 2024 |
| ADAR1 CAPITAL MANAGEMENT LLC Beneficial Owner of more than 10% of a Class of Security | Purchase at price 14.89 - 15.88 per share. | Indirect | 92,326 | Aug 12, 2024 |
| KIRITSY CHRISTOPHER P Director | Purchase at price 0.85 per share. | Direct | 8,500 | May 25, 2023 |
Related tickers
OKUR OnKure Therapeutics, Inc.
5.83
+10.42%
MLYS Mineralys Therapeutics, Inc.
10.27
-0.87%
ZBIO Zenas BioPharma, Inc.
7.62
+4.53%
MTVA MetaVia Inc.
1.8800
-0.53%
UR9.SG Clinuvel Pharmaceuticals Ltd
7.16
-0.49%
UTH.MU United Therapeutics Corp
343.80
-3.70%
ZLDAF Zelira Therapeutics Limited
0.3334
0.00%
FENC Fennec Pharmaceuticals Inc.
6.55
+1.24%
SEELQ Seelos Therapeutics, Inc.
0.0030
+2,900.00%
APGE Apogee Therapeutics, Inc.
42.50
+5.41%